KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Free Cash Flow (2016 - 2025)

Bausch Health Companies' Free Cash Flow history spans 17 years, with the latest figure at $403.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 18.59% year-over-year to $403.0 million; the TTM value through Dec 2025 reached $1.0 billion, down 20.4%, while the annual FY2025 figure was $1.0 billion, 20.4% down from the prior year.
  • Free Cash Flow for Q4 2025 was $403.0 million at Bausch Health Companies, up from $314.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $501.0 million in Q3 2021 and bottomed at -$1.3 billion in Q3 2022.
  • The 5-year median for Free Cash Flow is $266.0 million (2023), against an average of $164.5 million.
  • The largest YoY upside for Free Cash Flow was 857.41% in 2022 against a maximum downside of 362.87% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at -$54.0 million in 2021, then skyrocketed by 857.41% to $409.0 million in 2022, then fell by 28.61% to $292.0 million in 2023, then soared by 69.52% to $495.0 million in 2024, then decreased by 18.59% to $403.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Free Cash Flow are $403.0 million (Q4 2025), $314.0 million (Q3 2025), and $190.0 million (Q2 2025).